Can brepocitinib be formulated into an effective topical therapy to treat mild-to-moderate chronic plaque psoriasis?

Journal Article Corrected proof Can brepocitinib be formulated into an effective topical therapy to treat mild-to-moderate chronic plaque psoriasis? Get access William C Cranwell, William C Cranwell Sinclair DermatologyDermatology Institute of Victoria Correspondence: William C. Cranwell. Email: wcranwell@gmail.com Search for other works by this author on: Oxford Academic Google Scholar Rodney D Sinclair Rodney D Sinclair Sinclair DermatologyUniversity of Melbourne, Melbourne, VIC, Australia Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, ljad157, https://doi.org/10.1093/bjd/ljad157 Published: 08 May 2023 Article history Received: 30 April 2023 Accepted: 03 May 2023 Published: 08 May 2023 Corrected and typeset: 14 June 2023